<DOC>
	<DOCNO>NCT01657786</DOCNO>
	<brief_summary>Postoperative nausea vomiting ( PONV ) common distress complication patient undergo general anesthesia . However , although 5-hydroxytryptamine type 3 ( 5-HT3 ) receptor antagonists significantly reduce PONV , report 35 % patient treated ondansetron experience PONV . Though cause failure ondansetron treatment clear , investigator assume polymorphism 5-HT3 receptor gene would contribute inter-individual variation . In study , investigator examine whether polymorphisms 5-HT3 receptor gene affect efficacy ondansetron prevent PONV patient undergo general anesthesia laparoscopic surgery .</brief_summary>
	<brief_title>Association 5-HT3 Receptor Gene Polymorphism With Efficiency Ondansetron Postoperative Nausea Vomiting</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Adult patient ( 2090 year age ) schedule undergoing laparoscopic surgery undergo general anesthesia Patients previous history drug allergy , administration antiemetic drug within 24 hour , nausea/vomiting within 24 hour liver kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>ondanstron</keyword>
	<keyword>gene polymorphism</keyword>
	<keyword>postoperative nausea vomit</keyword>
	<keyword>laparoscopic surgery general anesthesia</keyword>
</DOC>